Notice Number: NOT-NS-08-019

Key Dates
Release Date: February 21, 2008

Issued by
National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov/)

Purpose

This Notice announces the participation of the National Institute on Drug Abuse (NIDA) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in NOT-NS-08-009, for competitive administrative supplements to generate reagents for production of high-quality low-cost monoclonal antibodies by the NIH-funded NeuroMab Facility. 

The following Institutes continue to participate in NOT-NS-08-009:

National Institute of Mental Health (NIMH) (http://www.nimh.nih.gov)
National Institute on Deafness and Other Communication Disorders (NIDCD) (http://www.nidcd.nih.gov)
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (http://www.niaaa.nih.gov/)
National Institute on Drug Abuse (NIDA) (http://www.nida.nih.gov)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (http://www.nichd.nih.gov)

Inquiries

Inquiries from NIDA- and NICHD-funded Principal Investigators should be directed to:

Nancy S. Pilotte, Ph.D., Chief
Functional Neuroscience Research Branch
Division of Basic Neuroscience and Behavioral Research
National Institute on Drug Abuse
6001 Executive Boulevard
Room 4282, MSC 9555
Bethesda, MD 20892-9555
For courier delivery:
Rockville, MD  20852
Tel:  301-435-1317
FAX:  301-594-6043
npilotte@nih.gov

James N. Coulombe, Ph.D.
Health Scientist Administrator
Developmental Biology, Genetics and Teratology
Center for Developmental Biology and Pediatric Medicine
National Institute of Child Health and Human Development
RM 4B01, MSC 7510
6100 Executive Blvd
Bethesda, MD 20892-7510
301 451-1390 Phone
301 480-0303 Fax
CoulombeJ@mail.nih.gov